Leaders in spray and aerosol product testing and contract services; trusted partner in product development from early stage R&D to manufacturing.
Hudson, MA
Joined September 2015
- Tweets532
- Following302
- Followers123
- Likes370
We’re attending! Let’s meet at #Respiratory #Drug #Delivery (RDD 2024), May 5-9, 2024, Tucson Arizona. Email us at contactus@proveris.com to schedule a private meeting with our team! #RDD2024 #RDDUS #RespiratoryDrugDelivery #Conference
We’re thrilled to share that our nasal drug product expert Maria Smith is presenting today at 2nd Novel Nasal Formulation & Delivery Summit, San Diego. Maria will speak on the topic, Guide to the Effects of Product Development on Nasal Spray Performance. #NasalDrugDelivery
bit.ly/3OTD4lb | Reduce the risk associated with nasal drug product development. Meet with a Proveris Laboratories expert during the 2nd Novel Nasal Formulation & Delivery Summit and find out how we can help you overcome your development challenges. #NasalDrugDelivery
Proveris Scientific retweeted
🚀 @proverisscience helps pharmaceutical companies developing orally inhaled and nasal drug products (OINDPs) reach the market sooner. And you can network with them at Formulation & Delivery US 2023!
📖 View networking opportunities: hubs.la/Q01_qG_N0
#FormulationSeries23
Thank you to attendees who joined our live webinar last week! It is now available for viewing on-demand.
pmi-live.com/events/improvin…
Schedule a time to discuss contactus@proveris.
#pMDIs
#inhalers
#drugdevelopment
#qualtycontrol
#delivereddoseuniformity
#DDU
#automatedtesting
Proveris Scientific is a proud sponsor of the 8th Pulmonary Drug Delivery Workshop. Those who are attending can meet with Dr. Deborah Jones in the exhibition area and attend her presentation entitled ‘Spray Characterization for in vitro Bioequivalence’. pulmonarydrugdelivery.org/
Proveris Scientific experts Maria Smith, Director of Application & Business Development and Lee Dalton, Director of Sales are in attendance at the Novel Nasal Fomulation & Delivery Summit. If you're attending, look for them during the networking session. #nasal #drugdelivery
Great to be a part of the Pulmonary & Nasal Delivery April 2023 issue! Proveris representatives are looking forward to discussing the topics presented in the publication at the upcoming @RDD2023 conference in Antibes, France next week! #inhaled #nasal #drugdevelopment
The latest issue is OUT! April 2023 #145, focusing on Pulmonary & Nasal Delivery from cover to cover. Packed with expert views and features from leaders in the field. Read here👉bit.ly/43YmlD9
#drugdelivery #inhalers #nasal #pulmonary #respiratory #combinationproducts
We’re excited to be participating in the RDD Europe 2023 Conference - May 2-5 in Antibes, France! If you’re attending, come meet with our team, join our workshop, and attend our poster presentation. #RDD2023 #RDDEurope
Vereo® Automated Actuators are used to provide fully controllable and repeatable actuation for completing a range of regulatory required in vitro tests for orally inhaled and nasal drug products #OINDPs: proveris.com/vereo-automated…
The Kinaero System eliminates the risks associated with improper manual shaking and shake-to-fire intervals in through-life testing of #pMDIs. It precisely automates shaking and actuation of up to 10 devices simultaneously. Learn more: proveris.com/kinaero-pmdi-fi…
Proveris Scientific retweeted
Join FDA and the Center for Research on Complex Generics for the “Considerations for and Alternatives to Comparative Clinical Endpoint and Pharmacodynamic Bioequivalence Studies for Generic Orally Inhaled Drug Products” workshop on April 20-21, 2023. complexgenerics.org/OIDP-CCE…
ALT Considerations for and Alternatives to Comparative Clinical Endpoint and Pharmacodynamic Bioequivalence Studies for Generic Orally Inhaled Drug Products - April 20-21, 2023, 8:30 AM - 5:30 PM, For more information visit: https://complexgenerics.org/events/
The Kinaero Cx System is a drug development tool for laboratories performing in vitro characterization of delivered aerosols from #pMDIs. It ensures sample consistency for #DDU and #APSD testing with the automation of critical parameters. proveris.com/kinaero-cx-pmdi…
Proveris Scientific retweeted
ICS-based inhaled therapy of longer than 6 months associated with reduction in all-cause mortality risk in patients with #COPD in a meta-analysis of 60 RCTs. Read the full original research in the January @journal_CHEST issue: hubs.la/Q01yxkNW0
#MedEd #MedTwitter
Are you attending #DDL2022 next week? Book a private meeting with our experts. Learn how Proveris Scientific and Proveris Laboratories can support your projects from development through to commercialization.
proveris.com//contact-us/
We're excited to share our latest publication in the Pulmonary and Nasal Delivery, Issue No.140 of OnDrug Delivery magazine. #OINDPs #pMDIs #SMIs
files.constantcontact.com/30…
Conference | Drug Delivery to the Lungs (DDL2022) is next week and we're delighted to be back in person, sponsoring and exhibiting again! If you’re attending, come meet the Proveris team at Stand 240.
#DDL #DDL2022 #OINDPs #analyticalinstruments
#contracttestservices
Conference | 9th Innovative Drug Delivery Solutions Summit, Suzhou China. Proveris’ partner in China, Ruty Li of Quantaflux is a conference speaker. If you are attending and would like to connect with Ruty, please send a private LinkedIn message or connect with him on WeChat.
Proveris is proud to be working on innovative orally inhaled and nasal drug products (OINDPs) to enable better management of chronic obstructive pulmonary disease (COPD). To learn how we are helping visit: proveris.com/about-us/
#Copdwareness #WorldCOPDDay
Our flagship Viota Software platform has been updated to include new functionality to measure Plume Front Velocity and Spray Duration on #pMDI and #SMI configurations of the #SprayVIEW System.
Learn more and download our Tech Note: proveris.com/proveris-scient… #OINDPs
